Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wheat germ agglutinin (WGA) is a 36 kDa dimeric lectin protein isolated from the germ of wheat (Triticum aestivum) that specifically recognizes and binds to N-acetyl-D-glucosamine and sialic acid carbohydrate residues [1]. In its native plant environment, WGA serves as a defense mechanism against pathogens and pests by interacting with chitinous structures in fungal cell walls and insect exoskeletons [2]. In biomedical research, WGA is a widely utilized tool for staining cell membranes, mapping neuronal pathways, and facilitating the targeted delivery of drugs across biological barriers, such as the blood-brain barrier and intestinal mucosa, due to its ability to undergo receptor-mediated endocytosis [3]. While not a conventional human therapeutic target, WGA is clinically significant as a dietary component that can influence gut health, exhibit insulin-mimetic properties, and potentially trigger inflammatory responses in sensitive individuals [4]. Furthermore, its high specificity for certain glycans makes it a valuable diagnostic biomarker for identifying changes in cell surface glycosylation associated with various cancers and metabolic disorders [5]. Sources: [1] UniProt Consortium, P02876 (Agglutinin isolectin 1). [2] PubChem Compound Summary, Wheat Germ Agglutinins. [3] PubMed PMID: 15808511 (WGA as a drug delivery tool). [4] PubMed PMID: 8338813 (Antinutritive effects of WGA). [5] PubMed PMID: 22543463 (WGA in cancer diagnostics).
Wheat germ agglutinin binds with high affinity to N-acetyl-D-glucosamine and sialic acid residues on cell surface glycoproteins and glycolipids, leading to cell agglutination, internalization via receptor-mediated endocytosis, or interference with receptor signaling [1][2].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wheat germ agglutinin (WGA) (WGA).